nach oben

Calcified Tissue International

Erschienen in:

01.02.2013 | Original Research

What Is Vitamin D Insufficiency? And Does It Matter?

verfasst von: Robert P. Heaney

Erschienen in: Calcified Tissue International | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The term nutrient “insufficiency,” as commonly used, refers to a nutritional status intermediate between classical, severe deficiency, and full normal. As both “deficiency” and “insufficiency” are causes of dysfunction and disease, there is no biological basis for a distinction between them. What is important to note is that, in the case of vitamin D, the preponderance of the evidence indicates that there is real, preventable disease in the range of vitamin D status values now labeled “insufficient.”

McCollum EV (1918) The “vitamin” hypothesis and the diseases referable to faulty diets. JAMA 71:937–940CrossRef

Goodwin JS, Tangum MR (1998) Battling quackery. Arch Intern Med 158:2187–2191PubMedCrossRef

Heaney RP, Roller S (2012) Nutrition, health policy, and the problem of proof. In: Coulston AM, Boushey CJ, Feerruzzi M (eds) Nutrition in the prevention and treatment of disease, 3rd edn. Elsevier, San Diego

Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, Zeisel SH (2010) Evidence-based criteria in the nutritional context. [Appendix: Amplification on certain of the points discussed in the paper (online only).] Nutr Rev 68:478–484

Heaney RP, Weaver CM, Blumberg J (2011) EBN (evidence-based nutrition) ver. 2.0. Nutr Today 46:22–26CrossRef

Heaney RP (2008) 2008 W.O. Atwater Memorial Lecture. Nutrients, endpoints, and the problem of proof. J Nutr 138:1591–1595PubMed

Willett WC (2010) The WHI joints MRFIT: a revealing look beneath the covers. Am J Clin Nutr 91:829–830PubMedCrossRef

Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, Amling M (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25:305–312PubMedCrossRef

Heaney RP (2012) The nutrient problem. Nutr Rev 70:165–169PubMedCrossRef

10.

IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC

11.

Heaney RP (2007) The case for improving vitamin D status. J Steroid Biochem Mol Biol 103:635–641PubMedCrossRef

12.

Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84:602–609PubMed

13.

Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA (1997) Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 67:342–348

14.

Webb AR (2006) Who, what, where and when—influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92:17–25PubMedCrossRef

15.

Holick MF (1985) The photobiology of vitamin D and its consequences for humans. Ann N Y Acad Sci 453:1–13PubMedCrossRef

16.

Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D₃: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D₃ synthesis in human skin. J Clin Endocrinol Metab 67:373–378PubMedCrossRef

17.

Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 2:1104–1105PubMedCrossRef

18.

Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, Stephensen CB (2010) Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140:542–550PubMedCrossRef

19.

Armas LAG, Dowell MS, Akhter M, Duthuluru S, Huerter C, Hollis BW, Lund R, Heaney RP (2007) Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UV-B dose and skin color. J Am Acad Dermatol 57:588–593PubMedCrossRef

20.

Barger-Lux MJ, Heaney RP (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:4952–4956PubMedCrossRef

21.

Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842–856PubMed

22.

Luxwolda ME, Kuipers RS, Kema IP, Dijck-Brouwer DAJ, Muskiet FAJ (2012) Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Br J Nutr. doi:10.1017/S0007114511007161

23.

Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(Suppl):1080S–1086SPubMed

24.

Holick MF (2008) Vitamin D: a D-lightful health perspective. Nutr Rev 66(Suppl 2):S182–S194PubMedCrossRef

25.

Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373PubMedCrossRef

26.

Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35:290–304PubMedCrossRef

27.

Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed

28.

Boucher BJ (2011) The 2010 recommendations of the American Institute of Medicine for daily intakes of vitamin D. Public Health Nutr 14:740PubMedCrossRef

29.

Giovannucci E (2011) Vitamin D, how much is enough and how much is too much? Public Health Nutr 14:740–741PubMedCrossRef

30.

Gorham ED, Garland CF (2011) Vitamin D and the limits of randomized controlled trials. Public Health Nutr 14:741–743PubMedCrossRef

31.

Cannell J (2011) Era or error? Public Health Nutr 14:743PubMedCrossRef

32.

Norman AW (2011) Vitamin D nutrition is at a crossroads. Public Health Nutr 14:744–745PubMedCrossRef

33.

Grant WB (2011) The Institute of Medicine did not find the vitamin D–cancer link because it ignores UV-B dose studies. Public Health Nutr 14:745–746PubMedCrossRef

34.

Schwalfenberg GK, Whiting SJ (2011) A Canadian response to the 2010 Institute of Medicine vitamin D and calcium guidelines. Public Health Nutr 14:746–748PubMedCrossRef

35.

Hollis BW, Wagner CL (2011) The vitamin D requirement during human lactation: the facts and IOM’s “utter” failure. Public Health Nutr 14:748–749PubMedCrossRef

36.

Heaney RP (2011) Finding the appropriate referent for vitamin D. Public Health Nutr 14:749–750PubMedCrossRef

37.

Holick MF (2011) The D-batable Institute of Medicine report: a D-lightful perspective. Endocr Prac 7:143–149

38.

Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26:455–467PubMedCrossRef

39.

Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S (1988) Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 3:133–144PubMedCrossRef

40.

Trivedi DP, Doll R, Khaw T (2003) Effect of four monthly oral vitamin D₃ (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 326:469–474PubMedCrossRef

41.

Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav J, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Intern Med 169:551–561PubMedCrossRef

42.

Bischoff-Ferrari HA, Willet WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation. JAMA 293:2257–2264PubMedCrossRef

43.

Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ 339:b3692PubMedCrossRef

44.

Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260PubMedCrossRef

45.

Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, Sidelnikov E, Willett WC, Orav EJ, Stähelin HB, Wolfram S, Jetter A, Schwager J, Henschkowski J, von Eckardstein A, Egli A (2012) Oral supplementation with 25(OH)D₃ versus vitamin D₃: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res 27:160–169CrossRef

46.

Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk. Am J Clin Nutr 85:1586–1591PubMed

47.

Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C (2001) Effects of a short-term vitamin D₃ and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86:1633–1637PubMedCrossRef

48.

Brooke OG, Brown IRF, Bone CDM, Carter ND, Cleeve HJW, Maxwell JD, Robinson VP, Winder SM (1980) Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. BMJ 15:751–754CrossRef

49.

Nursyam EW, Amin Z, Rumende CM (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38:3–5PubMed

50.

Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K (2008) Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 168:103–108PubMedCrossRef

51.

Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM (1998) Ultraviolet-B and blood pressure. Lancet 352:709–710PubMedCrossRef

52.

Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women. JAMA 303:1815–1822PubMedCrossRef

53.

Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46:1852–1857PubMedCrossRef

54.

Vieth R (2009) How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 29:3675–3684PubMed

55.

Heaney RP, Rafferty K (2008) The preponderance of the evidence: an example from the issue of calcium intake and body composition. Nutr Rev 67:32–39CrossRef

Titel: What Is Vitamin D Insufficiency? And Does It Matter?
verfasst von: Robert P. Heaney
Publikationsdatum: 01.02.2013
Verlag: Springer-Verlag
Erschienen in: Calcified Tissue International / Ausgabe 2/2013
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-012-9605-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Vitamin D and Its Role in Skeletal Muscle

Physiological Insights from the Vitamin D Receptor Knockout Mouse

Genetic Regulation of Vitamin D Levels

Vitamin D Assays: Past and Present Debates, Difficulties, and Developments

Casting New Light on the Sunshine Vitamin